EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 38 / No 5 (Mai 2022) Med Sci (Paris), 38 5 (2022) 487-492 References
Issue
Med Sci (Paris)
Volume 38, Number 5, Mai 2022
Nos jeunes pousses ont du talent !
Page(s) 487 - 492
Section Partenariat médecine/sciences - Écoles doctorales - Masters
DOI https://doi.org/10.1051/medsci/2022059
Published online 24 May 2022
  1. Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC microbiol 2009 ; 9 : 123. [CrossRef] [PubMed] [Google Scholar]
  2. Lafond M, Tauzin A, Bruel L, et al. α-Galactosidase and Sucrose-Kinase Relationships in a Bi-functional AgaSK Enzyme Produced by the Human Gut Symbiont Ruminococcus gnavus E1. Front Microbiol 2020; 11 : 579521. [CrossRef] [PubMed] [Google Scholar]
  3. Ramare F, Nicoli J, Dabard J, et al. Trypsin-dependent production of an antibacterial substance by a human Peptostreptococcus strain in gnotobiotic rats and in vitro. Appl Environ Microbiol 1993 ; 59 : 2876–2883. [CrossRef] [PubMed] [Google Scholar]
  4. Dabard J, Bridonneau C, Phillipe C, et al. Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl environ microbiol 2001 ; 67 : 4111–4118. [CrossRef] [PubMed] [Google Scholar]
  5. Gomez A, Ladiré M, Marcille F, et al. Trypsin mediates growth phase-dependent transcriptional regulation of genes involved in biosynthesis of ruminococcin A, a lantibiotic produced by a Ruminococcus gnavus strain from a human intestinal microbiota. J Bacteriol 2002 ; 184 : 18–28. [CrossRef] [PubMed] [Google Scholar]
  6. Ongey E.L., Giessmann R.T., Fons M, et al. Heterologous biosynthesis, modifications and structural characterization of Ruminococcin-A, a lanthipeptide from the gut bacterium Ruminococcus gnavus E1, in Escherichia coli. Front Microbiol 2018 ; 9 : 1688. [CrossRef] [PubMed] [Google Scholar]
  7. Pujol A, Crost EH, Simon G, et al. Characterization and distribution of the gene cluster encoding RumC, an anti-C lostridium perfringens bacteriocin produced in the gut. FEMS Microbiol Ecol 2011 ; 78 : 405–415. [CrossRef] [PubMed] [Google Scholar]
  8. Chiumento S, Roblin C, Kieffer-Jaquinod S, et al. Ruminococcin C, a promising antibiotic produced by a human gut symbiont. Sci. Adv. 2019; 5 : eaaw9969. [CrossRef] [Google Scholar]
  9. Roblin C, Chiumento S, Bornet O, et al. The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties. Proc Natl Acad Sci USA 2020; 117 : 19168–77. [CrossRef] [PubMed] [Google Scholar]
  10. Roblin C, Chiumento S, Jacqueline C, et al. The Multifunctional Sactipeptide Ruminococcin C1 Displays Potent Antibacterial Activity In Vivo as Well as Other Beneficial Properties for Human Health. Int J Mol Sci 2021; 22 : 3253. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.